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CORRESPONDENCE
An Escherichia coli O157:H7 Outbreak?
SIR—Friedman et al. [1] describe an outbreak of hemolytic
uremic syndrome and bloody diarrhea, which they ascribe
to an inadequately maintained swimming pool. They con-
sider the causative pathogen to be enterohemorrhagic Es-
cherichia coli (EHEC) O157:H7 on the basis of isolating the
organism from 1 case only and some serological evidence
from 17 (59%) of 29 cases. In only 2 cases was E. coli O157:
H7 sought by use of the Sorbitol Maconkey (SMAC) agar.
We consider that for an outbreak of infection in at least
29 people, a single isolation of the pathogen is inadequate
to ascribe the whole outbreak to it. An inadequately main-
tained swimming pool in a rural area, such as the one Freid-
man et al. describe, is likely to contain many E. coli, in-
cluding a variety of serotypes of EHEC, which would not
be detected by SMAC agar. The prevalence of antibodies to
the O157 antigen of E. coli in healthy individuals in rural
communities in Canada has been found to be as high as
12.5% [2]. Unless serological tests and/or cultures for other
EHEC are performed, we consider it inappropriate to as-
cribe an outbreak to a single EHEC serotype, such as O157:
H7. We have shown that if SMAC agar alone had been used
to test patients infected in a recent outbreak that was due
predominantly to EHEC O111:H2, the outbreak could have
been erroneously ascribed to EHEC O157:H7 [3].
Karl A. Bettelheim1 and Paul N. Goldwater2
1National Escherichia coli Reference Laboratory, Microbiological
Diagnostic Unit, Department of Microbiology and Immunology,
Melbourne University, Victoria, and 2Microbiology and Infectious
Diseases Department, Women’s and Children’s Hospital, North
Adelaide, South Australia, Australia
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Reply
SIR—We appreciate Drs. Bettelheim and Goldwater pointing out
that Escherichia coli O157:H7 is not the only E. coli serotype
that can cause bloody diarrhea and hemolytic uremic syndrome
[1]. As they stated in their 1996 letter to the editor [2], investi-
gators should look for all enterohemorrhagic E. coli (EHEC) in
these settings. However, our investigation was conducted 13
weeks after the pool party, so we did not attempt to perform
stool cultures and had to rely on serology to determine whether
the illnesses were related to the single culture-proven secondary
case. It is theoretically possible but highly unlikely that the single
person cultured early and appropriately had an E. coli O157:H7
infection, whereas other pool party attendees had infections
caused by other EHEC serotypes. E. coli O157 infections (0.85
reported infections/100,000 population/year in 1997–1998) are
unusual in Georgia, despite active statewide laboratory-based
surveillance.
Michael S. Friedman
Zuni Health Center, Indian Health Service, Zuni, New Mexico
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Aspergillus: An Increasing Problem in Tertiary Care
Hospitals?
SIR—We analyzed the microbiologic laboratory data regarding
isolation of Aspergillus species from clinical specimens of patients
hospitalized at the Detroit Medical Center from 1994 through
1998, and identified a steady increase in the number of Aspergillus
isolates recovered (figure 1). Duplicate isolates from the same
patients were few (!5%). Of the 423 isolates, 284 (66%) were
Aspergillus fumigatus. Common non-fumigatus species were As-
pergillus flavus and Aspergillus niger. The isolates included those
that caused disease as well as colonizers and contaminants. Mere
presence of Aspergillus species in clinical specimens does not im-
ply invasive disease. Invasion must, however, be strongly sus-
pected in certain settings such as neutropenia and bone marrow
transplantation [1, 2]. Most source patients were immunocom-
promised children and adults (i.e., cancer patients, marrow trans-
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Figure 1. Aspergillus species isolates from patients hospitalized at
the Detroit Medical Center, 1994–1998. Solid bars, Aspergillus fumi-
gatus; open bars, non-fumigatus aspergillus.
plant recipients, AIDS patients, and those receiving immuno-
suppressive agents).
Our data suggest that the incidence of aspergillosis may
be on the rise at our medical center. A large retrospective
study of aspergillosis conducted at a transplant center has
observed a similar trend [3]. There may be several reasons
for this increase: an increase in the number of immunocom-
promised hosts in the hospital setting, a heightened aware-
ness of aspergillosis among clinicians that causes them to
perform more fungal diagnostic tests and so detect fungal
infections more often in clinical specimens, better fungal
isolation techniques in the laboratory, and/or an increase in
the number of building construction sites around hospitals.
Another contributing factor may be the recent availability
of triazoles (e.g., fluconazole) for better treatment of and
prophylaxis for candidal infections.
P. H. Chandrasekar, George Alangaden,
and Elias Manavathu
Division of Infectious Diseases, Wayne State University School
of Medicine, Detroit Medical Center, Detroit, Michigan
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African Trypanosomiasis
SIR—Sinha et al. [1] have provided an excellent review of
African trypanosomiasis in travelers from the United States.
Their review purports to represent “all or nearly all” of the
US clinical experience with East African trypanosomiasis in
the past 30 years. However, their series does not include a
case of fulminant East African trypanosomiasis that we had
reported in conjunction with the Centers for Disease Control
and Prevention (CDC) in 1989 [2].
Our patient, a previously healthy 58-year-old woman, pre-
sented with fever 10 days after sustaining a tsetse fly bite
while on a photographic safari in Rwanda. This case was
complicated by adult respiratory distress syndrome, cardiac
arrhythmias, thrombocytopenia, lactic acidosis, and hepatic
and renal failure, but ultimately responded to treatment with
suramin. In addition, spurious hypoglycemia, apparently re-
lated to in vitro metabolism of glucose by high concentra-
tions of trypanosomes in initial blood specimens, was dem-
onstrated. This phenomenon had not been reported
previously in trypanosomiasis, although in our report we
referenced another case acquired in 1983 in which, retro-
spectively, spurious hypoglycemia was likely to have been
present. This case was reported in 1986 [3] and is included
in the review by Sinha et al., but evidence that suggested
possible spurious hypoglycemia documented in CDC inter-
nal records was not included in the published case report.
East African trypanosomiasis may be a fulminant infec-
tion that involves multiple organ systems. Such cases are
readily diagnosed by peripheral blood smears and are over-
whelmingly likely to be reported to the CDC. Further review
of the archives of the Parasitic Diseases Drug Service of the
CDC might disclose other cases not listed in this recent
review.
Roger E. Nieman and John J. Kelly
Associates in Infectious Diseases, Abington, Pennsylvania
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Screening for Latent Tuberculosis in Sexually
Transmitted Disease Clinics
SIR—I read with interest the article by Nolan [1] in Clinical
Infectious Diseases. Dr. Nolan discusses strategies for targeted
screening for latent tuberculosis infection in such venues as jails,
needle-exchange programs, and health clinics. In 1993, we con-
ducted a study of tuberculin skin testing among attendees of
an inner city sexually transmitted diseases (STD) clinic [2]. The
prevalence of positive skin test results was 34%. Compliance
with return visits for skin test interpretation was doubled by
use of a simple incentive package of condoms, candy, and a
fact sheet on tuberculosis. I agree with Nolan that identification
and treatment of individuals with latent tuberculosis is a po-
tentially important contributor to the prevention of tuberculosis
in the United States. STD clinics, which generally serve a
younger clientele who may benefit from isoniazid prophylaxis
and which may have a high prevalence of infection, should be
added to the list of appropriate screening sites.
Jane R. Schwebke
From the Department of Medicine, University of Alabama
at Birmingham, Birmingham, Alabama
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Nosocomial Bloodstream Infections: Are Positive
Blood Cultures Misleading?
SIR—We read with great interest the article of Edmond et al. [1]
on nosocomial bloodstream infections and were impressed by
the findings and the originality of some of the analyses. However,
although the trend for increase in gram-positive pathogens is
already well established [2], the finding of 32% coagulase-negative
staphylococci (CNS) in nosocomial bloodstream infections (BSI)
far exceeds the findings of previous studies (11% from nation-
wide data [3] and 18% in critically ill patients [4]). Our concern
is that many, if not most, of the CNS isolates included here
represent contamination. All of the criteria used in this study
could not assure that these isolates represent true bacteremias.
The presence of intravascular catheters, the initiation of anti-
microbial therapy, and the presence of fever are almost universal
characteristics of patients from whom blood cultures are
obtained.
The problem of distinguishing between true pathogens and
contaminants in blood isolates has not been satisfactorily re-
solved to date [5], despite its everyday occurrence. The most
common criterion used in many studies for this purpose is the
exclusion of cases where potential skin contaminants grow only
from a single bottle. Although there is the possibility of excluding
a few true bacteremias by this method, it ensures that not too
many contaminants are included. This criterion can be improved
with the use of some method of bacterial fingerprinting for the
comparison of 2 isolates from the same patient, but unfortunately
there is no practical and inexpensive technique to be widely rec-
ommended. The best approach of which we are aware is the
individual consideration of all clinical and bacteriologic data
(signs, symptoms, underlying conditions, presence of devices,
number of blood-culture bottles taken per clinical episode and
number positive, source of specimens for cultures [e.g., obtained
through lines or by peripheral venipunctures], how did symptoms
resolve, etc.) by an experienced expert in infectious diseases. We
admit that these are not practical criteria, since they are subjec-
tive, cumbersome, and not feasible for a multicenter study such
as this one.
We hope that this letter will stimulate discussion regarding the
issue raised, since it continues to be an important challenge to
formulate reliable and objective criteria to distinguish between
true and false bacteremias.
Yardena Siegman-Igra and Chaim Ernst
Infectious Disease Unit, Tel-Aviv Sourasky Medical Center
and Sackler School of Medicine Tel-Aviv University, Israel
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Is an Isolated Initial Phase of a Tick-Borne
Encephalitis a Common Event?
SIR—Tick-borne encephalitis (TBE) is one of the most impor-
tant human infections of the CNS in several European coun-
tries. It has been endemic primarily in southern Scandinavia
and central Europe, including a large part of Slovenia. The
etiological agent of TBE is an RNA virus belonging to the
Flavivirus genus of the family Flaviviridae. The hard tick Ixodes
ricinus is the principal vector of the central European virus
subtype. It is well known that in at least two-thirds of patients
who develop CNS involvement, the disease has a characteristic
biphasic course. After the initial phase of illness that corre-
sponds to viremia, followed by an asymptomatic interval, the
second phase presents signs and symptoms of meningitis, me-
ningoencephalitis, or even meningoencephalomyelitis [1].
Seroepidemiological studies regarding TBE virus infection in
endemic areas of various European countries demonstrated
conclusively that asymptomatic infections are common [2–4].
In some of the reports it was also suggested that there is an
abortive form of TBE virus infection, which is manifested only
by a febrile headache without meningeal involvement (i.e., the
initial phase of the illness without subsequent CNS involve-
ment) [1, 3, 5, 6]. However, it seems that this suggestion relies
more on data for eastern TBE than on data for central Eu-
ropean (western) TBE [7], which are dubious with respect to
the frequency of abortive forms of TBE. Thus, in a compre-
hensive review article on TBE, published recently in Clinical
Infectious Diseases [7], the authors state that the initial phase
of the illness is followed by “an afebrile and relatively asymp-
tomatic period, lasting 2–10 days. In about one-third of patients
infected, the second phase of disease develops.” A logical con-
clusion from such a statement, as suggested by Kunz [8], would
be that two-thirds of clinically symptomatic TBE virus infec-
tions manifest themselves only by the initial phase of the illness.
However, later in the article, in a discussion of clinical mani-
festations, the authors report that in the western European
literature this initial phase of TBE is usually not recognized,
possibly (according to Ackerman et al. [2]) because of the small
proportion of such cases.
We challenged these quite diverse statements with the findings
of 2 prospective studies we have performed during the last few
years. In one study we searched for the presence of thrombo-
cytopenia in addition to a well-known leukopenia during the
initial phase of TBE [9], and in the second study (still ongoing),
we examined the etiology of febrile illnesses that occur within
6 weeks after a tick bite [10]. Inclusion criteria for both studies
were the presence of a febrile illness after a tick bite, as well
as clinical and laboratory assessment (including demonstration
of IgM and IgG antibodies against TBE virus using diagnostic
kits [Immunozyme, FSME, Immuno AG, Vienna]) at initial
examination, 14 days, and 6 weeks. Using this approach, we
were able to study patients referred to us by primary physicians
who were in the initial phase of TBE and check for the eventual
appearance of the second, encephalitic phase of the disease.
From 1994 through 1997, 165 patients aged 115 years were
referred to the Department of Infectious Diseases at the Uni-
versity Medical Centre, Ljubljana, Slovenia. These patients had
a febrile illness associated with a tick bite during the 6 weeks
before the onset of the disease and either normal CSF exam-
ination results or complete absence of clinical signs of men-
ingitis. During a follow-up of 6 weeks, infection with TBE virus
was demonstrated in 44 (26.7%) of 165 patients by the ap-
pearance of specific IgM and IgG antibodies against TBE virus.
All of these patients lived in the central part of Slovenia in a
region where TBE is known to be endemic, and none of them
had been vaccinated against TBE. However, during the follow-
up period, all 44 of the patients developed the second, menin-
goencephalitic phase of the disease; that is, all had clinically
biphasic course of the illness with CSF abnormalities (pleo-
cytosis) during the second phase.
Therefore, none of our 44 patients developed only the iso-
lated initial phase of the disease without later developing men-
ingitis or meningoencephalitis. Our findings strongly support
the idea that the abortive form of central European TBE is
rare, if it exists at all. However, our findings do not negate the
fact that a majority of patients are not recognized as having
an infection with TBE virus during the initial phase of their
disease.
Stanka Lotricˇ-Furlan,1 Tatjana Avsˇicˇ-Zˇupanc,2
and Franc Strle1
1Department of Infectious Diseases, University Medical Centre
and 2Institute for Microbiology and Immunology, Medical Faculty,
Ljubljana, Slovenia
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Antiviral Therapy for Neurological Manifestations
of Enterovirus 71 Infection
SIR—An analysis of 97 enterovirus 71 (EV 71) culture-pos-
itive cases from Taiwan revealed CNS involvement in 35%
of cases [1]. MRI showed involvement of the midbrain, pons,
and medulla oblongata, which seem to be the target foci for
EV 71 replication. It was demonstrated that early detection
a CNS lesion by MRI and CSF examination was likely to
provide useful information regarding the brain stem en-
cephalitis [1] and thus contribute to judicious clinical
management.
In all probability, the clinical course of illness in Taiwa-
nese patients may have been modified by an early thera-
peutic intervention with IFN. IFN-a therapy within 24 h of
admission halted progression of disease in 2 patients. A 16-
month-old child with bulbar paralysis due to type 1 wild
poliovirus was treated with 1 million doses of im IFN-a,
and a 34-year-old man with bulbar paralysis due to type 2
vaccine poliovirus was treated with 3 million doses of im
IFN-a, both for 16 days [2]. Both showed improvement
within a day or two. IFN therapy, after an indication of
brain lesions by MRI, could ensure prompt recovery with
no residual sequelae and might lower the existing mortality
associated with EV 71 infections.
In addition to the usefulness of MRI to diagnose EV 71
infection, proton magnetic resonance spectroscopy (MRS)
is also of value to monitor the functional activity of neurons
by scrutinizing the metabolic changes among individual neu-
rons. In a 53-year-old woman with Kreutzfeldt-Jakob dis-
ease, neuronal loss was demonstrated by reduced N-acety-
laspartatex, reduced creatinine-phosphocreatinine ratio and
increased sorbitol levels [3].
Earlier detection of viral involvement of EV 71 target
nuclei as determined by MRI and MRS, if followed by im-
mediate IFN-a therapy, should reverse the viral damage to
neurons. Furthermore, such early detection could help in
deciding whether to prescribe IFN-a along with the prom-
ising antienteroviral drug pleconaril [4]. This combined ther-
apeutic recipe would be associated with reduced mortality
and negligible residual morbidity.
Subhash C. Arya
Centre for Logistical Research and Innovation, New Delhi, India
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Clinically Relevant Aeromonas Species
SIR—In the October 1999 issue of Clinical Infectious Diseases,
an update of the current nomenclature, taxonomy, and clas-
sification of aerobic and facultative bacteria is presented [1].
While checking the species of Aeromonas in the updated list,
we were surprised to find Aeromonas enteropelogenes included
as a valid species, although it was synonymized a long time
ago with Aeromonas trota on the basis of 16S rRNA sequences
[2]. This synonymization has been further confirmed in recent
studies with other molecular methods [3–5] and with pheno-
typical tests [6].
It is encouraging, however, that Aeromonas sobria, a mis-
nomer classically used by clinicians to refer to Aeromonas ve-
ronii biovar sobria, was not included in the list. In fact, Aero-
monas sobria sensu stricto is considered a valid species of
environmental origin that is not commonly reported in clinical
cases [7].
Another important consideration are the criteria employed
for inclusion of species on the list. The genera Aeromonas now
encompasses 14 species. In the recent overview/review of the
genus carried out by Janda and Abbott [7], only 5 species,
including 1 with 2 biovars, were considered pathogenic. Three
of these are referred to as major pathogens (Aeromonas hydro-
phila, Aeromonas caviae, and A. veronii biovar sobria), since
they account for 185% of clinical isolates of this genus [8],
whereas the other 3 (A. veronii biovar veronii, Aeromonas jan-
daei, and Aeromonas schubertii) are considered minor patho-
gens [7]. The list published in Clinical Infectious Diseases in-
cludes these 5 species, as well as 5 others (Aeromonas
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allosaccharophila, Aeromonas bestiarum, Aeromonas media,
Aeromonas salmonicida, and A. trota), in addition to the invalid
species mentioned above. If the detection of these species in-
dependently of their pathological significance in clinical samples
is the basis for inclusion, it would be appropriate to include
these last 5 species, but then Aeromonas encheleia and Aero-
monas eucrenophila, isolated from an ankle fracture and a
wound, respectively, would be missing [7]. Aeromonas salmon-
icida was classified by Janda and Abbott [7] under the group
of environmental species. However, similar to the experience of
other investigators, we encountered this species with a low in-
cidence in feces of patients with diarrhea [9]. We agree, there-
fore, with the authors of the list published in Clinical Infectious
Diseases [1] that these species should be included. In view of
these comments, it is important that the list as published be
amended in order to be properly updated.
Maria Jose´ Figueras,1 Josep Guarro,1
and Antonio Martı´nez-Murcia2
1Departamento de Ciencias Me´dicas Ba´sicas, Facultad
de Medicina y Ciencias de la Salud, Universidad Rovira y Virgili,
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Universidad de Alicante, Alicante, Spain
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Klebsiella pneumoniae Necrotizing Fasciitis
Associated with Diabetes and Liver Cirrhosis
SIR—We read with interest the two articles in Clinical Infectious
Diseases on the association of necrotizing fasciitis and Klebsiella
pneumoniae liver abscess by Hu et al. [1] and Dylewski and
Dylewski [2]. Although K. pneumoniae is a common co-patho-
gen in patients with polymicrobial necrotizing fasciitis, the bac-
terium is rarely the sole cause of this serous soft tissue infection
[3]. As was pointed out by Hu et al. [1], all 4 patients who had
liver abscess and fasciitis also had diabetes. Therefore, an
awareness of the spectrum of underlying diseases in association
with monomicrobial klebsiella fasciitis is important. We de-
scribe a case of K. pneumoniae necrotizing fasciitis and spon-
taneous bacterial peritonitis in a patient with diabetes and
cirrhosis.
A 52-year-old man with diabetes and hepatitis B–related liver
cirrhosis (Pudge-Child grade C) was admitted for evaluation
of fever, and abdominal pain and distension. Physical exami-
nation revealed stigmata of chronic liver disease, ascites, and
mild diffuse abdominal tenderness. There was no evidence of
infection elsewhere. Abdominal centesis on the day of admis-
sion was unsuccessful. Ultrasonography of the hepatobiliary
system revealed no evidence of liver abscess or biliary infection.
Blood culture was obtained and he was given empirical treat-
ment with cefoperazone/sulbactam for presumed spontaneous
bacterial peritonitis. Two days later, blood culture yielded K.
pneumoniae that was susceptible to cefoperazone/sulbactam,
amoxicillin/clavulanate, and ofloxacin. Screening for produc-
tion of extended-spectrum b-lactamase was negative. Culture
of ascitic fluid obtained on day 6 was negative, but there was
an increased polymorphonuclear leukocyte (PML) count of
/L, a very low protein level of 5 g/L, and a low pH6129 3 10
of 7. The patient’s condition improved over the next few days
and the antibiotic was continued for a total of 10 days.
Four days later, the patient was readmitted for evaluation
of a 2-day history of left leg pain, erythema, and swelling. His
temperature was 35.67C; pulse rate, 140; and blood pressure,
67/33 mm Hg. There were multiple patches of purpuric lesions
over the right groin, left calf, and mid-thigh. Skin necrosis was
present in one of the mid-thigh lesions. Emergency surgery re-
vealed necrotizing fasciitis, and extensive debridement was per-
formed. Parenteral antibiotics including amoxicillin/clavulanate
and ofloxacin were administered. Cultures of blood and tissue
specimens from the calf both yielded a pure growth of K. pneu-
moniae. The antibiogram and biotype of this isolate were iden-
tical to that of the isolate 10 days earlier. The patient’s condition
deteriorated further despite intensive therapy, and he died 5
days later.
Both diabetes and liver cirrhosis predisposed our patient to
serious bacterial infection. Patients with diabetes have elevated
rates and severity of K. pneumoniae infections, including pneu-
monia, bacteremia, hepatic abscess, and meningitis [4–6]. In-
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fections are also frequent in cirrhotic patients because of their
defective defense mechanisms. The most important is sponta-
neous ascitic fluid infection, which has a prevalence of
10%–27% among cirrhotic patients who are admitted to hos-
pitals with ascites. This type of infection is usually caused by
an enteric bacterium, such as Escherichia coli or Klebsiella spe-
cies. In one-third to one-half of the cirrhotic patients with spon-
taneous ascitic fluid peritonitis, bacteremia was also present [7].
Diagnosis of spontaneous ascitic fluid peritonitis is made on
the basis of clinical features, an increased ascitic fluid PML
count ( cells/L), and/or positive ascitic fluid culture.61 250 3 10
Spontaneous ascitic fluid peritonitis cannot be definitely con-
firmed in our patient because a sample of the ascitic fluid was
not available before administration of antibiotics. However,
spontaneous ascitic fluid peritonitis is likely because of the ab-
dominal signs, absence of an evident intra-abdominal surgically
treatable source of infection, abnormal parameters in the ascitic
fluid (day 6), and absence of another source for the K. pneu-
moniae bacteremia. Our case is unique in that a rare compli-
cation occurred shortly after an apparently adequate course (10
days) of treatment. During the second hospital admission, there
was no evidence of recurrent spontaneous ascitic fluid infection
or liver abscess. The bilateral necrotizing fasciitis in the lower
limbs, therefore, could be spontaneous or more likely a result
of metastatic seeding during the earlier ascitic fluid infec-
tion–related bacteremia.
Monomicrobial K. pneumoniae necrotizing soft tissue infec-
tion is rare. In addition to the 4 reported cases in diabetics with
liver abscess, 2 cases have been described in association with
bacteremia and advanced cirrhosis [1,2,8]. Data from the small
number of reported cases thus suggest that monomicrobial K.
pneumoniae is associated with diabetes and cirrhosis. When K.
pneumoniae bacteremia occurs in these patients, clinicians
should be vigilant about metastatic soft tissue infections.
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Handwashing—The Semmelweis Lesson
Misunderstood?
SIR—Larson’s excellent review about hand hygiene [1] highlights
the persisting reluctance in the United States to use alcohol-based
hand disinfection for preventing the spread of hospital-acquired
microorganisms. This letter is intended to provide some further
clarifications about Semmelweis’ discovery to introduce hand dis-
infection and not handwashing into clinical practice.
More than 150 years ago, Ignaz Semmelweis (1818–1865) dem-
onstrated that puerperal fever was a contagious disease caused
by infectious organisms, which were spread from patient to pa-
tient via the hands of health care workers (HCWs). This discovery
led to the introduction of hand dips with chlorinated lime at
Vienna General Hospital. Since then, many scientists have cited
Semmelweis’ observations, but, amazingly, grossly misleading im-
pressions still arise about Semmelweis and his original idea of
antiseptic hand disinfection, often wrongly cited as “handwash-
ing” in the English-language literature [2–4]. In fact, Semmelweis
never promoted handwashing with soap and water; he was op-
posed to it, since he wrote: “The cadaveric particles clinging to
the hands are not entirely removed by the ordinary method of
washing the hands with soap.… For that reason, the hands of
the examiner must be cleansed with chlorine, not only after han-
dling cadavers, but likewise after examining patients” [5].
Nowadays, sink-based handwashing with water and antiseptic
soaps could reduce the risk of cross-transmission. However, many
studies have shown that compliance of HCWs with recom-
mended handwashing practice remains unacceptably low, in the
range of 10% to 50% [6]. Noncompliance is even higher in in-
tensive care units (ICUs), during procedures that carry a high
risk for contamination, and during periods of increased workload
[7]. As recently suggested by Pittet et al., full compliance with
handwashing guidelines seems unrealistic. The average hand
wash duration in routine patient care ranges between 8 and 20
seconds, which is too short for most handwashing agents to be
fully effective [7, 8]. Moreover, HCWs need 40–80 seconds for
washing hands at the sink and returning to their workplace. In
ICUs, where at least 20 opportunities for handwashing occur per
CID 2000;30 (June) Correspondence 991
hour of care, the amount of time spent with handwashing at the
sink quickly becomes prohibitive [7, 9].
In contrast, waterless, alcohol-based hand rubs, readily avail-
able at the bedside in small bottles or dispensers, allow much
faster hand hygiene during patient care, achieve higher and more
rapid microbial killing, and may even exert a prolonged anti-
microbial effect when chlorhexidine or similar substances are
added [1, 8–10]. Although alcohol-based hand disinfection has
been used in many countries around the world and has been
shown to be superior to handwashing in many important mi-
crobiological and technical aspects [11], including decreased skin
irritation when emollients [1, 10] are added, the use of alcohol-
based hand rubs remains very limited in the US health care
system. This is remarkable given that Semmelweis’ original ex-
perience was actually related to hand disinfection and not hand-
washing! We conclude that there is an urgent need to reconsider
the true message of Semmelweis and evaluate ways to implement
and disseminate hand disinfection in the United States.
Stephan Harbarth
Division of Infectious Diseases, Children’s Hospital,
Boston, Massachusetts
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Association of Primary Pneumocystis carinii
Infection and Sudden Infant Death Syndrome
SIR—Histological evidence indicates that primary Pneumocys-
tis carinii infection is associated with sudden infant death syn-
drome (SIDS) [1]. Fifty-five (31%) of 177 infants who died in
the community from no apparent cause had positive lung spec-
imens, whereas only 10 (2.9%) of 342 infants who died of mul-
tiple causes in hospitals had positive lung specimens (cases with
AIDS and malignancies were excluded from the study). We
recommend that the high prevalence of P. carinii infection in
infants with SIDS warrants further investigation [1].
In future studies, it will be useful to compare the iron status
of case patients with that of control subjects. As with other
microbial pathogens, P. carinii infection is associated with iron-
loaded patients [2] and is suppressed by iron chelator therapy
[3]. In a study of 66 infants who died of SIDS and 28 who died
of other causes, the hepatic median iron concentration was, at
autopsy, 296 mg/g wet weight and 105 mg/g wet weight, respec-
tively [4]. Moreover, increasing the iron concentration of infants
by feeding them iron supplements and/or iron-fortified milk
formula have been reported as a risk factor for developing SIDS
[5].
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